Correlation Between Canntab Therapeutics and Medipharm Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Canntab Therapeutics and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Canntab Therapeutics and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Canntab Therapeutics Limited and Medipharm Labs Corp, you can compare the effects of market volatilities on Canntab Therapeutics and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Canntab Therapeutics with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Canntab Therapeutics and Medipharm Labs.

Diversification Opportunities for Canntab Therapeutics and Medipharm Labs

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Canntab and Medipharm is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Canntab Therapeutics Limited and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Canntab Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Canntab Therapeutics Limited are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Canntab Therapeutics i.e., Canntab Therapeutics and Medipharm Labs go up and down completely randomly.

Pair Corralation between Canntab Therapeutics and Medipharm Labs

Assuming the 90 days horizon Canntab Therapeutics Limited is expected to generate 6.24 times more return on investment than Medipharm Labs. However, Canntab Therapeutics is 6.24 times more volatile than Medipharm Labs Corp. It trades about 0.04 of its potential returns per unit of risk. Medipharm Labs Corp is currently generating about 0.01 per unit of risk. If you would invest  1.76  in Canntab Therapeutics Limited on November 2, 2024 and sell it today you would lose (1.75) from holding Canntab Therapeutics Limited or give up 99.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Canntab Therapeutics Limited  vs.  Medipharm Labs Corp

 Performance 
       Timeline  
Canntab Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Canntab Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Canntab Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Medipharm Labs Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's forward indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Canntab Therapeutics and Medipharm Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Canntab Therapeutics and Medipharm Labs

The main advantage of trading using opposite Canntab Therapeutics and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Canntab Therapeutics position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.
The idea behind Canntab Therapeutics Limited and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios